Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2008
John Cavanagh, Ph.D.
N/A
Read More
2008
Richard A. Drachtman, M.D.
N/A
Read More
2008
Georgia Cancer Coalition 
N/A
Read More
2008
Michael Nieder, M.D.
N/A
Read More
2008
Jack Pledger, Ph.D.
N/A
Read More
2008
Jeffrey Wolf, M.D. Tom Martin, M.D.
N/A
Read More
2008
Jim Valvano Fellowship in Pediatric Cancer
N/A
Read More
2008
Scott Powers, Ph.D., Gary K. Schwartz, M.D., Raffaella Sordella, Ph.D.
Multiplex RNAi Screening for Rational Combination Therapies in Melanoma
Read More
2008
John P. Leonard, M.D., Ari Melnick, M.D.
Epigenetic Therapy for Diffuse Large B Cell Lymphoma
Read More
2008
Howard Kipen, M.D., M.P.H., Helmut Zarbl, Ph.D.
Chemoprevention of Breast and Prostate Cancers in Shift Workers by Dietary Methylselenocysteine:...
Read More
2008
Judy E. Garber, M.D., M.P.H., Daniel P. Silver, M.D., Ph.D.
Development of Predictive Markers of Treatment Response in Basal-like Breast Cancer
Read More
2008
Tanya B. Dorff, M.D., Amy S. Lee, Ph.D., Valter D. Longo, Ph.D., David I. Quinn, MBBS, Ph.D., FRACP
Pre-clinical and Clinical Studies of Fasting-induced Differential Stress Resistance to Enhance Cancer...
Read More
2008
Raju Chaganti, Ph.D., Robert Motzer, M.D.
Molecular Mechanism of Sunitinib Response in RCC Patients: Novel Approaches to Therapy...
Read More
2008
Hal Broxmeyer, Ph.D., Sherif S. Farag, M.D., Ph.D., David Jones, Ph.D.
Enhancing Cord Blood Stem Cell Engraftment by CD26 Inhibition in Patients with...
Read More
2007
Ian J. Davis, M.D., Ph.D.
Targeting dysregulated transcription factors in pediatric malignancies *The research project that receives...
Read More
2007
James Brugarolas, M.D., Ph.D.
Evaluation of the mTOR pathway in renal-cell carcinoma and in model systems.
Read More